(UPDATED) To help manage thrombotic risk after transcatheter mitral valve replacement (TMVR), clinicians should consider routine use of oral anticoagulation and regular clinical and imaging follow-up, ...
The Sapien M3 transcatheter mitral valve replacement system won FDA approval -- making it the first on the market to utilize ...
Transcatheter mitral valve replacement (TMVR) with the Tendyne system (Abbott) results in anatomic and functional improvements in the left side of the heart within a month of the procedure, with the ...
Clinicians should use echocardiography, an ultrasound that shows the heart's structure and function, when determining whether patients with heart failure and a leaking heart valve are likely to ...
Over the past few years, whispers about the promised of transcatheter mitral valve replacement (TMVR) technology have grown louder. Excitement about TMVR is reaching an all-time high, as several large ...
TipRanks on MSN
MicroPort CardioFlow reports strong one-year AltaValve TMVR data as device advances in global trials
MicroPort CardioFlow Medtech Corp. ( ($HK:2160) ) just unveiled an update. MicroPort CardioFlow Medtech Corporation announced the formal release ...
Transcatheter aortic valve replacement (TAVR) is one of the most significant cardiovascular scientific advancements of the past decade, but its sister procedure, transcatheter mitral valve replacement ...
New York, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Transcatheter Mitral Valve Repair (TMVR) Pipeline Report including Stages of Development, Segments, ...
The transcatheter mitral valve replacement (TMVR) market is projected to grow at a CAGR of 20% over the forecast period. Major factors driving growth include increased prevalence of mitral valve ...
Patients undergoing transcatheter mitral valve replacement (TMVR) who receive direct oral anticoagulants (DOACs) have fewer bleeding and thrombotic events and shorter hospital stays than those taking ...
Abbott Laboratories ABT recently received Food and Drug Administration (“FDA”) approval for its Tendyne transcatheter mitral valve replacement (TMVR) system. The Tendyne system replaces mitral valves ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback